Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

β2-Adrenergic receptor supports prolonged theta tetanus-induced LTP.

Journal of neurophysiology | 2012

The widespread noradrenergic innervation in the brain promotes arousal and learning by molecular mechanisms that remain largely undefined. Recent work shows that the β(2)-adrenergic receptor (β(2)AR) is linked to the AMPA-type glutamate receptor subunit GluA1 via stargazin and PSD-95 (Joiner ML, Lise MF, Yuen EY, Kam AY, Zhang M, Hall DD, Malik ZA, Qian H, Chen Y, Ulrich JD, Burette AC, Weinberg RJ, Law PY, El-Husseini A, Yan Z, Hell JW. EMBO J 29: 482-495, 2010). We now demonstrate that the β(2)AR plays a prominent role in long-term potentiation (LTP) induced by a train of 900 stimuli at 5 Hz (prolonged theta-tetanus-LTP, or PTT-LTP) in the hippocampal CA1 region in mice, which requires simultaneous β-adrenergic stimulation. Although PTT-LTP was impaired in hippocampal slices from β(1)AR and β(2)AR knockout (KO) mice, only β(2)AR-selective stimulation with salbutamol supported this PTT-LTP in wild-type (WT) slices, whereas β(1)AR-selective stimulation with dobutamine (+ prazosin) did not. Furthermore, only the β(2)AR-selective antagonist ICI-118551 and not the β(1)AR-selective antagonist CGP-20712 inhibited PTT-LTP and phosphorylation of GluA1 on its PKA site S845 in WT slices. Our analysis of S845A knockin (KI) mice indicates that this phosphorylation is relevant for PTT-LTP. These results identify the β(2)AR-S845 signaling pathway as a prominent regulator of synaptic plasticity.

Pubmed ID: 22338020 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: AG-017502
  • Agency: NHLBI NIH HHS, United States
    Id: HL-079031
  • Agency: NEI NIH HHS, United States
    Id: R01 EY014882
  • Agency: NINDS NIH HHS, United States
    Id: NS-035563
  • Agency: NHLBI NIH HHS, United States
    Id: HL-62494
  • Agency: NEI NIH HHS, United States
    Id: R01-EY-014882
  • Agency: NHLBI NIH HHS, United States
    Id: HL-70250

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Shank2 scaffold protein (antibody)

RRID:AB_10674119

This monoclonal targets Shank2 scaffold protein

View all literature mentions

Anti-Shank2 Antibody (antibody)

RRID:AB_2254586

This monoclonal targets Shank2

View all literature mentions

Anti-PSD-95 Antibody (antibody)

RRID:AB_2292909

This monoclonal targets PSD 95

View all literature mentions